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The gut microbiota plays an important role in host health, in particular by its barrier
effect and competition with exogenous pathogenic bacteria. In the present study, the
competition of Bifidobacterium pseudolongum PV8-2 (Bp PV8-2) and Bifidobacterium
kashiwanohense PV20-2 (Bk PV20-2), isolated from anemic infant gut microbiota and
selected for their high iron sequestration properties, was investigated against Salmonella
Typhimurium (S. Typhi) and Escherichia coli O157:H45 (EHEC) by using co-culture tests
and assays with intestinal cell lines. Single and co-cultures were carried out anaerobically
in chemically semi-defined low iron (1.5 µM Fe) medium (CSDLIM) without and with
added ferrous iron (30 µM Fe). Surface properties of the tested strains were measured
by bacterial adhesion to solvent xylene, chloroform, ethyl acetate, and to extracellular
matrix molecules, mucus II, collagen I, fibrinogen, fibronectin. HT29-MTX mucus-
secreting intestinal cell cultures were used to study bifidobacteria competition, inhibition
and displacement of the enteropathogens. During co-cultures in CSDLIM we observed
strain-dependent inhibition of bifidobacterial strains on enteropathogens, independent
of pH, organic acid production and supplemented iron. Bp PV8-2 significantly (P < 0.05)
inhibited S. Typhi N15 and EHEC after 24 h compared to single culture growth. In
contrast Bk PV20-2 showed less inhibition on S. Typhi N15 than Bp PV8-2, and no
inhibition on EHEC. Affinity for intestinal cell surface glycoproteins was strain-specific,
with high affinity of Bp PV8-2 for mucin and Bk PV20-2 for fibronectin. Bk PV20-2
showed high adhesion potential (15.6 ± 6.0%) to HT29-MTX cell layer compared to
Bp PV8-2 (1.4 ± 0.4%). In competition, inhibition and displacement tests, Bp PV8-2
significantly (P < 0.05) reduced S. Typhi N15 and EHEC adhesion, while Bk PV20-
2 was only active on S. Typhi N15 adhesion. To conclude, bifidobacterial strains
selected for their high iron binding properties inhibited S. Typhi N15 and EHEC in
co-culture experiments and efficiently competed with the enteropathogens on mucus-
producing HT29-MTX cell lines. Further studies in complex gut ecosystems should
explore host protection effects of Bp PV8-2 and Bk PV20-2 mediated by nutritional
immunity mechanism associated with iron-binding.
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INTRODUCTION
Bifidobacteria are among the first commensal anaerobic bacteria
that reach high levels in the infant gut within the first week of
life, representing up to 50–80% of the gut bacteria (Jost et al.,
2012; Turroni et al., 2012). The establishment of bifidobacteria
in the gut has been associated with a broad range of beneficial
effects on host health, such as modulation of intestinal microbiota
composition, prevention of infection and immune-modulation
(Broekaert and Walker, 2006; Yatsunenko et al., 2012). Inhibition
of pathogens in the gut by bifidobacteria might be due to
production of inhibitory substances, inhibition of epithelial and
mucosal invasion of pathogens, competition for limited nutrients
and/or the stimulation of mucosal immunity (Marco et al., 2006;
Turroni et al., 2014). Potential inhibition mechanisms include the
production of short-chain fatty acids and subsequent local pH
decrease (Fukuda et al., 2011), or other antimicrobial compounds
such as bacteriocins (Cheikhyoussef et al., 2008; Dobson et al.,
2012; Martinez et al., 2013). Bifidobacteria can also compete
with pathogens for adhesion to intestinal epithelial sites and
nutrients, enhancing resistance to colonization of pathogenic
bacteria (Collado et al., 2007; Aires et al., 2010).
The gut microbiota is constantly challenged by different
stress factors, including enteropathogens, such as Salmonella
and Escherichia coli O157:H45 (EHEC; Wardlaw et al., 2010).
Pathogenesis of Salmonella requires its adhesion to host cell
surfaces followed by invasion of intestinal epithelial cells, leading
to systemic spreading (Sansonetti, 2004; Haraga et al., 2008;
Santos et al., 2009). EHEC pathophysiology is attributed to
the effects of shiga toxins encoded on the pO157 plasmid,
survival to harsh conditions and the formation of attaching-
and-effacing lesions on epithelial cells (Muller et al., 2009;
Melton-Celsa et al., 2012; Thiennimitr et al., 2012). To
inhibit pathogen infection in the gut, commensal intestinal
microorganisms such as bifidobacteria, should be able to compete
for corresponding niches. Bifidobacteria have been reported to
occupy attachment sites, therefore preventing pathogen invasion
and translocation (Bernet et al., 1994; Goto and Kiyono, 2012).
The inhibitory activity and mechanisms of bifidobacteria against
enteropathogens have been investigated by microbe-microbe and
cell-microbe interaction models (Collado et al., 2007).
Different intestinal epithelial cell lines exhibiting specific
characteristics and functions of the gut epithelium are used
to study host-pathogen interactions. HT29-MTX cell line is a
mucus-secreting clone of the HT-29 intestinal epithelial cell
line suitable for mimicking the mucosal surface of the gut
epithelium, which acts as the first line of interaction between
the microbiota and its host (Lesuﬄeur et al., 1990; Gagnon
et al., 2013). The intestinal mucus layer functions as a physical
barrier, separating the epithelium from the bacterial load in the
intestinal lumen. Mucus is also an important nutrient source for
gut microbes and promotes selective adhesion of gut bacteria
to the intestinal mucus layer. Interactions with the intestinal
mucus layer is a property of commensal gut bacteria that
can enhance the barrier function of the intestinal epithelium
by limiting access of pathogens to this specific niche. The
adherence to intestinal epithelial cells is therefore an important
characteristic for beneficial gut bacteria, enhancing persistence in
the gut, pathogen exclusion effects and specific bacterial and host-
immune system interactions (Izquierdo et al., 2008; Bron et al.,
2012).
The ability of bacteria to establish in the intestine is
heavily dependent on competition for nutrients (Andrews et al.,
2003). For example iron is an essential micronutrient for
growth, proliferation, and persistence for most gut bacteria,
including bifidobacteria and enteropathogens (Turroni et al.,
2014). Pathogens such as S. Typhi and EHEC are known to
possess efficient iron sequestration mechanisms that contribute
to their pathogenicity and competitiveness in the gut (Berkley
et al., 2005; Wardlaw et al., 2010; Cassat and Skaar, 2013;
Monack and Hultgren, 2013; Winter et al., 2013). These systems
have been directly linked to the ability of strains with high
iron sequestration properties to establish efficiently in the gut
(Weinberg, 2009; Kortman et al., 2012). In a previous study we
reported isolation of 56 bifidobacterial strains from stools of
breast fed, iron-deficient and anemic Kenyan infants (Vazquez-
Gutierrez et al., 2015c). Isolated strains were characterized and
compared to public culture collection strains. Bifidobacterium
kashiwanohense PV20-2 (Bk PV20-2) and Bifidobacterium
pseudolongum PV8-2 (Bp PV8-2) were selected for their
high siderophore activity (iron-chelating molecules) and iron
internalization. Analysis of the complete genome allowed to
identify ferrous and specific ferric iron operons in both strains
(Vazquez-Gutierrez et al., 2015a,b,c). Furthermore, a ferrous
iron-binding protein and other proteins with adhesive properties
were identified in the extracellular fraction of Bk PV20-2 together
with. In the extracellular proteome of Bp PV8-2 a ferric iron-
binding protein belonging to the ferric iron transport operon was
shown. In the present study, the inhibitory activity of Bp PV8-2
and Bk PV20-2 was investigated during co-cultures with S. Typhi
N15 and EHEC as a function of iron concentrations (1.5 and
30 µM ). Surface properties were tested by bacterial adhesion
to solvent (BATS) and extracellular matrix molecules (ECMs)
and the competition for epithelial binding sites was studied in
HT29-MTX intestinal cellular model.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Bifidobacterium pseudolongum DSMZ20099 (Bp DSMZ20099)
and B. kashiwanohense DSMZ21854 (Bk DSMZ21854) were
obtained from the German collection of microorganisms (DSMZ;
Leibniz, Germany). B. pseudolongum PV8-2 (Bp PV8-2) and
B. kashiwanohense PV20-2 (Bk PV20-2), were obtained from the
culture collection of the Laboratory of Food Biotechnology (ETH
Zurich, Switzerland). Salmonella enterica ssp. enterica serovar
Typhimurium N15 (S. Typhi N15) a clinical isolate obtained
from the National Centre for Enteropathogenic Bacteria and
Listeria (NENT, University of Zurich, Switzerland) and E. coli
O157:H45 (EHEC) were kindly provided by Prof. Roger Stephan.
Bifidobacteria were routinely cultured in de Man, Rogosa, and
Sharpe (MRS) broth (Biolife, Italy) supplemented with 0.05%
of L-cysteine hydrochloride monohydrate (cys; Sigma-Aldrich,
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Switzerland). Enteropathogens were cultured in Luria-Bertani
(LB) broth (Becton Dickinson, Switzerland) unless otherwise
specified. Cells suspensions and serial dilutions were carried
out in peptone water at pH 6.5, containing 1.5 g/L peptone
water (CDH Bioscience, India) and 0.6 g/L cys (peptone-cys).
Bifidobacterial viable cell counts were determined on MRS-cys
agar (Becton Dickinson, Switzerland) plates, incubated for 72 h
under anaerobiosis in anaerobic jars. S. Typhi and EHEC
enumeration was done in Mac-Conkey agar (Oxoid, Switzerland)
incubated 24 h at 37◦C. A chemically semidefined low iron
medium (CSDLIM) with a low iron concentration of 1.5 µM
was used for co-culture interaction assays. The CSDLIM medium
was previously used to test siderophore production with the CAS
assay (Vazquez-Gutierrez et al., 2015c). Iron supplementation
of the CSDLIM medium was achieved by adding 30 µM of
ferrous iron (Sigma-Aldrich, Switzerland), corresponding to the
iron concentration previously reported to increase Salmonella
and EHEC pathogenicity (Cernat and Scott, 2012; Kortman
et al., 2012). Iron concentration in CSDLIM was measured
by graphic furnace atomic absorption spectrometry (Vazquez-
Gutierrez et al., 2015c).
Inhibitory Activity of B. pseudolongum
PV8-2 and B. kashiwanohense PV20-2
during Co-cultures with
Enteropathogens
Growth interactions of bifidobacteria and enteropathogens were
investigated in CSDLIM with and without added ferrous iron
as follow. The corresponding strains were first cultured twice at
37◦C in MRS-cys for 24 h and LB broth for 12 h, respectively.
Bacterial cells were harvested by centrifugation (Biofuge Primo,
Heraeus, Switzerland) at 4◦C, 16,000 × g for 10 min. The
supernatant was discarded and the pellet was resuspended
in peptone-cys water to an OD600 nm of 1.0. Hungate tubes
containing 10 mL of CSDLIM with headspace filled with CO2
were inoculated with log10 6.5 ± 0.05 CFU/mL Bp PV8-2, log10
6.6 ± 0.13 CFU/mL Bk PV20-2, log10 5.5 ± 0.06 CFU S. Typhi
N15/mL and log10 5.4± 0.15 CFU/mL EHEC for both mono- and
co-cultures. Hungate tubes were incubated at 37◦C for 24 h and
samples were taken at 0, 12, and 24 h from the same tube through
septum for absorbance determination at OD600 nm (Biowave,
CO8000, Biochrom, Ltd, England), pH and viable cell counts.
Short chain fatty acid (SCFA) concentrations were measured
by high performance liquid chromatography (HPLC; Thermo
Fisher Scientific, Switzerland) as previously described (Cleusix
et al., 2008). Briefly, 1 mL culture samples were centrifuged
for 12 min at 10,000 × g and 4◦C. Supernatant was filtered
with a 0.45 µm nylon membrane (Infochroma AG, Switzerland)
directly into HPLC vials. Analysis was performed at a flow rate
of 0.4 mL/min with 10 mM sulphuric acid as eluent with an
injection volume of 20 µL. Mean metabolite concentrations were
expressed in millimolar (mM). Three independent repetitions of
mono- and co-cultures in CSDLIM with and without ferrous iron
supplementation (30 µM ferrous iron) were carried out.
To test the effects of pH decrease and SCFA on
enteropathogens growth inhibition, S. Typhi N15 and EHEC
were incubated at 37◦C for 12 h, at pH 4.5 (pH measured
at the end of co-cultures) and SCFA concentrations where
enteropathogen counts began to decrease during co-cultures.
After centrifugation at 4◦C and 16,000× g for 10 min, cell pellets
were suspended in peptone-cys water and adjusted to OD600 nm
1.0. Then hungate tubes containing 10 mL of CSDLIM pH 4.5,
7 mM lactate and 13 mM acetate, were inoculated with log10
5.4 ± 0.06 CFU/mL S. Typhi N15 and log10 5.3 ± 0.13 CFU/mL
EHEC, which were the viable cell counts reached in co-cultures
after 12 h incubation. Hungate tubes were incubated for 24 h at
37◦C and 1 mL sample was taken every 4 h to determine pH,
absorbance at 600 nm and viable cell counts. The experiment was
performed in three independent replicates in CSDLIM with and
without ferrous iron supplementation.
Surface Properties of Bifidobacterial
Strains
The BATS assay was used to investigate cell surface properties
of bifidobacterial strains according to Xu et al. (2009), with
slight modifications. Surface hydrophobicity, electron donor and
acceptor properties were determined based on the affinity of
bifidobacteria to xylene (apolar solvent), chloroform (polar acidic
solvent) and ethyl-acetate (polar basic solvent). Bifidobacteria
were cultured in MRS-cys and CDSLIM as described above.
Briefly, cell pellets were re-suspended in phosphate-buffered
saline (PBS), pH 7.3 to an OD600 nm of 1.0. A volume of
3 mL of cell suspension was mixed with 1 mL of either xylene,
chloroform (electron-acceptor), or ethyl-acetate (electron-donor;
Sigma-Aldrich, Switzerland). The mixture was vortexed for
1 min and allowed to stand for 5 min to allow separation
into two distinct phases. Then 1 mL of the aqueous phase was
carefully collected with a pipette and OD600 nm was measured
using a UV-Visible spectrophotometer CARY 1Bio (Varian,
Switzerland). The decrease in absorbance of the aqueous phase
after contact with solvent was used as a measure of the cell surface
hydrophobicity or electron-donor/electron-acceptor interaction.
BATS was expressed by BATS (%) = (1 – A5 min/A0 min) × 100,
where A0 min and A5 min were the absorbance before and after
extraction with the solvents, respectively (Xu et al., 2009). Three
independent replicates of the experiment were carried out.
Adhesion to Different Intestinal Cell
Surface Molecules
The adhesion affinities of bacteria to the ECMs of intestinal
epithelial cells were tested as described previously (Sillanpaa et al.,
2008), with slight modifications. Briefly, a solution of type II
mucus (Sigma-Aldrich, Switzerland) at 50 µg/mL was prepared
in Tris-HCl (0.1 M, pH 8). Collagen I, fibrinogen and fibronectin
(all from Sigma-Aldrich, Switzerland) were resuspended at
10 µg/mL in PBS (Gibco, Switzerland), pH 7.5. Bovine serum
albumin (BSA; Sigma-Aldrich, Switzerland) was resuspended
at 50 µg/mL in Tris-HCl and used as control for unspecific
adhesion to protein surfaces. 100 µL of each suspension were
applied to wells of a MaxiSorpTM 96-well microtiter plate (Nunc,
Switzerland) and kept overnight at 4◦C for adsorption. After
removal of the liquid, adsorbed molecules were fixed for 10 min
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at 65◦C and subsequently blocked with 100 µL PBS 1% tween
20 per well for 1 h at 37◦C. Before application of bacteria, plates
were washed three times with 100 µL PBS 0.005% tween 20 to
remove unbound ECM, filled with 100 µL PBS and used within
24 h storage at 4◦C.
Bifidobacteria and enteropathogen strains were first cultured
in MRSc or LB media, respectively, then transferred and grown
in CDLSIM, as presented above. Briefly, cell pellets (24◦C,
16,000 × g during 10 min) were re-suspended in PBS at pH 5.5
and pH 7.5 to OD600 nm of 1.0. 100 µl of bacterial suspension
was applied in triplicates to coated plates and incubated for 1 h
at 37◦C to induce bacterial adhesion. Wells were washed three
times with 100 µL PBS 0.005% Tween 20 to remove unattached
bacteria and dried for 10 min at 65◦C. Adhered bacteria were
stained with 100 µL crystal violet (1 mg/mL, Sigma-Aldrich,
Switzerland) per well for 45 min at room temperature. Crystal
violet retained by fixed bacteria after three washing steps with
100 µL PBS was resolubilized in 100 µL citrate buffer (50 mM;
pH 4) under continuous shaking at 37◦C for 1 h. Absorbance
of solubilized crystal violet was measured at OD595 nm using a
Powerwave XS spectrophotometer (Bio Tek, Switzerland). The
experiment was carried out in three independent replicates.
In vitro Antagonism of Bifidobacteria
against Pathogen Adhesion to
HT29-MTX Cells
The mucus-secreting intestinal epithelial cell line HT29-MTX
was used to investigate adhesion properties of bifidobacteria
and enteropathogens, as described previously with slight
modifications (Gagnon et al., 2013). Briefly, HT29-MTX cells
were seeded in 24-well tissue culture plates (Bioswisstec,
Switzerland) at a concentration of 4 × 104 cells/well, and
grown in Dulbecco’s Modified Eagle Medium (DMEM; Sigma-
Aldrich, Switzerland) supplemented with 20% fetal bovine
serum (Invitrogen, Switzerland), 1% penicillin/streptomycin
(Life Technologies, Switzerland), and 1% non-essential amino
acids (Life Technologies, Switzerland), at 37◦C and 10% CO2
in a humidified incubator (RB150, Revco, Switzerland). Culture
medium was changed every other day and experiments were
performed 21 days post-seeding on fully differentiated, confluent
monolayers with mucus secretion verified using Alcian blue
(stains acid mucopolysaccharides) and periodic acid Schiff (stains
hexose and sialic acid-containing mucosubstances). After full
differentiation the medium was exchanged to antibiotic free
medium for 24 h. Tested bacterial cultures were grown in
CDLSIM medium and prepared as described above. Bacterial
cultures were washed with sterile 0.85% NaCl, and resuspended
in DMEM for application to the cell monolayers. Cell monolayers
were carefully washed with 500 µL of warm PBS. For all tests,
bifidobacteria were added at log10 7.7 ± 0.12 CFU/mL and
S. Typhi N15 and EHEC were added at approximately log10
6.3 ± 0.05 CFU/mL in DMEM to the HT29-MTX monolayer.
After 2 h incubation at 37◦C, HT29-MTX monolayers were
washed twice with PBS to remove non-attached bacteria and
detached using 0.25% trypsin-EDTA solution (Life Technologies,
Switzerland). Bacterial cell counts were determined as described
above. Adhesion was expressed as the percent ratio of adhered
bacteria to number of bacteria added to the HT29-MTX cells
monolayer. Experiments were performed in triplicates on three
consecutive passages of the HT29-MTX cell line.
To determine the inhibition of pathogen adhesion by
bifidobacteria the method of Gagnon et al. (2013) was used
with slight modifications. Briefly, bifidobacteria were applied to
the cell monolayer for 1 h. Then the well was washed once
with PBS to remove non-adhering cells and the tested pathogen
was added for a further incubation of 1 h. Enumeration of
adhered bacteria was performed after serial dilution on respective
media. To examine if adhered pathogenic bacteria could be
displaced by the addition of bifidobacteria, enteropathogens were
incubated 1 h and, after PBS washing, bifidobacteria were added
and incubated 1 h. To investigate the ability of bifidobacteria
to competitively exclude enteropathogens, bifidobacteria and
pathogenic bacteria were added simultaneously to the HT29-
MTX monolayer and incubated for 2 h. All incubations were
done at 37◦C and 10% CO2. HT29-MTX monolayers were
washed twice with PBS to remove non-attached bacteria, and
treated with a 0.25% trypsin-EDTA solution for 15 min, for
bifidobacteria and enteropathogens enumeration as stated earlier.
Activity of bifidobacteria strains to compete with, displace and
inhibit the adhesion of S. Typhi N15 and EHEC to the intestinal
epithelial cell line HT29-MTX was expressed by the adhesion
ratio. This corresponded to the ratio of the percentage of adhered
bifidobacteria or pathogenic bacteria following simultaneous
addition divided by the percentage of adhesion of the bacteria
added alone to the cell culture (Serafini et al., 2013). All the above
tests were carried out in triplicates on three consecutive passages
of the HT29-MTX cell line.
Statistical Analysis
To assess differences between treatments in inhibitory activity
in mono- and co-culture experiments, and surface properties of
bifidobacteria strains, the means of three independent repetitions
were compared using un-paired Student’s t-test. ANOVA with
post hoc Tukey test was used to assess significant affinity
of bifidobacteria and pathogens to ECM when compared
to PBS control (P-value < 0.05). Significant differences in
competition, inhibition and displacement experiments were
tested by comparing the means of three independent repetition
of the HT29-MTX cell line using un-paired Student’s t-test.
Statistical significance was established at P-value < 0.05 and SPSS
software 17.0 (SPSS, Inc., Chicago, IL, USA) was used.
RESULTS
Inhibitory Activity of B. pseudolongum
PV8-2 and B. kashiwanohense PV20-2
against Enteropathogens
The inhibitory activities of Bp PV8-2 and Bk PV20-2 against
S. Typhi N15 and EHEC were tested in co-culture experiments
and compared to mono-cultures of the same strains (Figures 1
and 2). Mono-cultures of Bp PV8-2 reached maximum viable
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FIGURE 1 | Viable cell counts during mono- (dashed lines) and co-cultures (continuous lines) in low iron CSDLIM medium: (A) Bifidobacterium
pseudolongum PV8-2 (Bp PV8-2) and S. Typhimurium N15 (S. Typhi N15); (B) Bp PV8-2 and Escherichia coli O157:H45 (EHEC); (C) Bifidobacterium
kashiwanohense PV20-2 (Bk PV20-2) and S. Typhi N15; (D) Bk PV20-2 and EHEC. Bp PV8-2, Bp PV8-2 in co-culture, S. Typhi N15,
S. Typhi N15 in co-culture, Bk PV20-2, Bk PV20-2 in co-culture, EHEC, EHEC in co-culture. Stars (∗) denote a significant (P < 0.05)
difference compared with mono-cultures (mean ± SD, n = 3).
cell counts of log10 8.1 ± 0.1 CFU/mL with and without iron
supplementation, and pH of 4.5 ± 0.06 and 4.2 ± 0.01 after
24 h incubation in CDSLIM medium, respectively. In decreasing
concentration the main organic acids produced were acetate,
lactate and formate (Table 1). Iron supplementation significantly
(P < 0.05) increased production of all metabolites, by 12, 17,
and 29% for acetate, lactate and formate, respectively, when
compared to cultures in unsupplemented media. Similarly, Bk
PV20-2 in mono-cultures reached viable cells counts of log10
7.7± 0.2 CFU/mL with and without iron, and pH was 5.3± 0.04
and 4.7 ± 0.01, respectively. Organic acid productions were
also significantly (P < 0.05) increased with iron, by 27% for
acetate and 20% for lactate. No significant effect of iron on
growth or metabolite production was observed during mono-
cultures of enteropathogens. EHEC reached cell counts of log10
7.9 ± 0.1 CFU/mL after 12 h and remained stable until 24 h
of culture. pH after 24 h was 4.88 ± 0.01 and 5.05 ± 0.02,
with and without iron supplementation, respectively. Main
metabolites were lactate and acetate for S. Typhi N15 and EHEC
(Table 1).
Viable cell counts of S. Typhi N15 significantly decreased
(P < 0.05) by log10 2.5 ± 0.1 CFU/mL in co-culture with
Bp PV8-2 and by log10 1.1 ± 0.1 CFU/mL with Bk PV20-2
after 24 h when compared with mono-cultures of S. Typhi
N15 (Figures 1A,C). pH after 24 h of co-cultures of S.
Typhi N15 with Bp PV8-2 was 4.19 ± 0.02 and 4.21 ± 0.02
and with Bk PV20-2 4.62 ± 0.01 and 4.59 ± 0.01, with
or without iron supplementation, respectively. EHEC counts
significantly decreased after 12 h when co-cultured with Bp
PV8-2 compare to monocultures (Figure 1B). No significant
differences were observed when co-culturing EHEC with Bk
PV20-2. Metabolites produced during co-cultures of S. Typhi
N15 and EHEC with Bp PV8-2 were in decreasing order
acetate, lactate and formate (Table 1), whereas with Bk PV20-
2 only acetate and lactate were identified (Tables 1 and 2). No
significant differences in metabolites were observed following
iron supplementation of the media. No significant effect of
iron supplementation was detected on EHEC growth during
co-cultures (Figures 1 and 2).
Salmonella Typhi and EHEC were tested for the inhibitory
conditions observed after 12 h of co-culture with bifidobacterial
strains. CDSLIM medium was supplemented with 13 mM
of acetate and 7 mM of lactate at pH 4.5 and growth
tested for 24 h. S. Typhi N15 and EHEC viable cell
counts remained constant (log10 5.4 ± 0.12 CFU/mL) during
24 h. In contrast a significant viability decrease of S. Typhi
N15 (Bp PV8-2 and Bk PV20-2) and EHEC (Bp PV8-2)
was measured during co-cultures with both bifidobacteria
between 12 and 24 h for both iron levels (Figures 1A–C
and 2A–C).
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FIGURE 2 | Viable cell counts during co-cultures in iron supplemented (30 µM) CSDLIM medium: (A) B. pseudolongum PV8-2 (Bp PV8-2) and S.
Typhimurium N15 (S. Typhi N15); (B) Bp PV8-2 and E. coli O157:H45 (EHEC); (C) B. kashiwanohense PV20-2 (Bk PV20-2) and S. Typhi N15; (D) Bk
PV20-2 and EHEC. Bp PV8-2, Bp PV8-2 in co-culture, S. Typhi N15, S. Typhi N15 in co-culture, Bk PV20-2, Bk PV20-2 in
co-culture, EHEC, EHEC in co-culture. Stars (∗) denote a significant (P < 0.05) difference compared with mono-cultures (mean ± SD, n = 3).
TABLE 1 | pH and concentrations of metabolites (mM) in culture supernatant measured with HPLC after 24 h incubation of mono- and co-cultures of
Bifidobacterium pseudolongum PV8-2 in CSDLIM media (mean ± SD, n = 3).
B. pseudolongum PV8-2 Acetate Lactate Formate pH
with iron supplementation
B. pseudolongum PV8-2 20.81 ± 0.35 8.04 ± 0.34 3.85 ± 0.23 4.50 ± 0.06
S. Typhimurium N15 5.26 ± 0.09 14.82 ± 0.26 − 4.87 ± 0.02
B. pseudolongum PV8-2/S. Typhimurium N15 21.81 ± 0.82 10.15 ± 0.57 3.20 ± 0.30 4.19 ± 0.02
E. coli O157:H45 5.55 ± 0.07 12.72 ± 0.21 − 4.88 ± 0.01
B. pseudolongum PV8-2/E. coli O157:H45 21.90 ± 0.75 9.87 ± 0.30 4.79 ± 0.21 4.15 ± 0.01
with iron supplementation (30 µM)
B. pseudolongum PV8-2 23.28 ± 0.36∗ 9.43 ± 0.20∗ 4.96 ± 0.75∗ 4.20 ± 0.01∗
S. Typhimurium N15 5.47 ± 0.28 14.07 ± 0.56 − 5.16 ± 0.06
B. pseudolongum PV8-2/S. Typhimurium N15 21.92 ± 0.72 10.64 ± 0.36 2.53 ± 0.25 4.21 ± 0.02
E. coli O157:H45 5.93 ± 0.14 11.87 ± 0.09 − 5.05 ± 0.02
B. pseudolongum PV8-2/E. coli O157:H45 22.81 ± 0.82 9.73 ± 0.43 4.82 ± 0.33 4.18 ± 0.01
Stars (*) denote a significant (P < 0.05) difference in the respective metabolite production of cultures performed in iron supplemented compared with unsupplemented
medium.
Surface Properties of Bifidobacteria
Strains
Physico-chemical characteristics of bifidobacteria cell surfaces,
such as hydrophobicity, electron-donor and electron-acceptor
properties, are related to adhesion to intestinal epithelial cells.
The affinity of bifidobacteria strains to different solvents,
xylene, chloroform and ethyl-acetate, was determined using
the BATS assay to quantify surface hydrophobicity. Bp PV8-2
showed similar surface properties as the type strain DSMZ20099
(Figure 3). Under iron-limited conditions affinity to hydrophobic
xylene was 84.4 ± 3.6% for Bp PV8-2 and 88.3 ± 11.6% for
Bp DSMZ20099. Affinity to chloroform, an acidic solvent, was
99.2± 1% for Bp PV8-2 and 98.4± 3.5% for Bp DSMZ20099. No
hydrophobic, electron donor/acceptor properties were observed
for Bk PV20-2 (Figure 3B), whereas Bk DSMZ21854 showed
hydrophobic and electron-donor properties only when grown
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TABLE 2 | pH and concentrations of metabolites (mM) in culture
supernatant measured with HPLC after 24 h incubation of mono- and
co-cultures of Bifidobacterium kashiwanohense PV20-2 in CSDLIM media
(mean ± SD, n = 3).
B. kashiwanohense
PV20-2
Acetate Lactate pH
without iron supplementation
B. kashiwanohense PV20-2 8.69 ± 0.55 5.08 ± 0.20 5.30 ± 0.04
S. Typhimurium N15 5.26 ± 0.09 14.82 ± 0.26 4.87 ± 0.02
B. kashiwanohense
PV20-2/S. Typhimurium
N15
10.18 ± 0.40 10.04 ± 0.29 4.62 ± 0.01
E. coli O157:H45 5.55 ± 0.07 12.72 ± 0.21 4.88 ± 0.01
B. kashiwanohense
PV20-2/E. coli O157:H45
9.55 ± 0.29 9.18 ± 0.28 4.64 ± 0.01
with iron supplementation (30 µM)
B. kashiwanohense PV20-2 11.00 ± 0.09∗ 6.08 ± 0.06∗ 4.70 ± 0.01∗
S. Typhimurium N15 5.47 ± 0.28 14.07 ± 0.56 5.16 ± 0.06
B. kashiwanohense
PV20-2/S. Typhimurium
N15
12.67 ± 0.34∗ 8.63 ± 0.17∗ 4.59 ± 0.01
E. coli O157:H45 5.93 ± 0.14 11.87 ± 0.09 5.05 ± 0.02
B. kashiwanohense
PV20-2/E. coli O157:H45
12.29 ± 0.16∗ 8.02 ± 0.27∗ 4.61 ± 0.01
Stars (*) denote a significant (P < 0.05) difference in the respective
metabolite production of cultures performed in iron supplemented compared with
unsupplemented medium.
in CDSLIM (Figure 3D). Electron-acceptor properties were not
observed for any of the strains tested. Bifidobacteria strains
showed less affinity to all solvents when grown in MRS-cys
compared to CDSLIM.
Adhesion to Different Intestinal Cell
Surface Molecules
The intestinal epithelial cell surface is covered by glycoproteins,
such as type II mucus, collagen, fibrinogen and fibronectin,
and can serve as attachment sites for microbes. The affinity of
bacteria to glycoproteins can therefore influence strain capacity
to compete for epithelial binding sites. No significant adhesion to
the unspecific protein binding control BSA nor to collagen I was
shown for the tested strains when compared with the uncoated
control wells (Figures 4A,B). Bp PV8-2, showed significant
(P < 0.05) adhesion at pH 5.5 to type II mucin and Bk PV20-2 and
Bk DSMZ21854 to fibronectin when compared with the uncoated
control (Figure 4A). S. Typhi N15 showed significant (P < 0.05)
adhesion to type II mucin, fibronectin, and fibrinogen. EHEC
bound to type II mucin and fibronectin when compared with the
uncoated control. At pH 7.5, all strains showed similar affinity
to glycoproteins, BSA and the uncoated control (Figure 4B),
except S. Typhi N15 that showed significantly (P < 0.05) higher
adhesion to mucin II, fibrinogen, and fibronectin.
In vitro Inhibition of Bifidobacteria
Strains against S. Typhimurium N15 and
EHEC
The ability to adhere to mucus and epithelial cells is an
important feature for the barrier effect of bifidobacteria. The
adhesion ratios of Bk PV20-2 and Bk DSMZ21854 to mucus-
secreting HT29-MTX were significantly higher (15.6± 6.0% and
12.7 ± 2.4%, respectively) when compared to both Bp PV8-2
and Bp DSMZ20099 (1.4 ± 0.4% and 1.3 ± 0.3%, respectively).
Very high adhesion ratios of S. Typhi N15 and EHEC were
measured, with 87.8 ± 17.5% and 137.6 ± 51.7%, respectively,
likely reflecting growth of the enteropathogens during the
test.
The ability of bifidobacteria strains, to compete, displace
and inhibit the adhesion of enteropathogens was tested on
the HT29-MTX epithelial cell model. Both strains exhibited
competitive abilities when added together with S. Typhi N15 in
the competition assay, as shown by adhesion ratios significantly
higher than 1 (1.88 ± 0.64 for Bp PV8-2 and 1.76 ± 0.51 for Bk
PV20-2; Figures 5A,B). In contrast, adhesion ratios lower than
1 (P < 0.05) were measured for S. Typhi N15 in competition
with Bp PV8-2 (0.67 ± 0.08) and Bk PV20-2 (0.80 ± 0.22),
indicating that enteropathogen adhesion was decreased in the
presence of both bifidobacteria. In the displacement assay, Bp
PV8-2 and Bk PV20-2 strains induced the release of S. Typhi N15
bound to HT29-MTX, indicated by adhesion ratios of 0.43± 0.15
and 0.44 ± 0.13, respectively. The inhibition assay showed that
adhered bifidobacteria prevented the attachment of S. Typhi N15
and stably occupied a sufficient number of adhesion sites on the
surface of HT29-MTX cells. Bp PV8-2 showed the highest degree
of inhibition of S. Typhi N15 (0.08 ± 0.04) compared to Bk
PV20-2 (0.21± 0.12).
Bk PV20-2 was not able to competitively exclude EHEC in the
competition assay, as indicated in Figure 5D. In the displacement
assay with EHEC added first, Bp PV8-2 showed low adhesion
ratio of 0.16 ± 0.03 compared with 0.51 ± 0.31 for EHEC which
was not significantly different from 1 (Figure 5C). This data
suggest that Bp PV8-2 could not displace previously adhered
EHEC. In the inhibition assay (Figure 5D), EHEC adhesion could
be significantly (P < 0.05) decreased by the presence of adhered
Bp PV8-2. Bk PV20-2 did not reduce adhesion of EHEC when
added simultaneously (competition assay) or after the addition of
EHEC (displacement assay).
DISCUSSION
Inhibitory Activity of B. pseudolongum
PV8-2 and B. kashiwanohense PV20-2
against Enteropathogens
Bifidobacteria play an essential role in the development
and homeostasis of the host’s immune system in infants
where they represent one of the first commensal anaerobic
bacteria colonizing the gut (Gupta and Garg, 2009). Efficient
competition for iron is a key factor for bacterial growth,
persistence and establishment in the intestine (Andrews et al.,
2003). In our previous research, B. pseudolongum PV8-2 and
B. kashiwanohense PV20-2 isolated from anemic infants in
Kenya were therefore selected for this study based on their high
iron sequestration capacity (Vazquez-Gutierrez et al., 2015c).
Their inhibitory activities against two strains of enteropathogens,
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FIGURE 3 | Adhesion affinity of (A) B. pseudolongum PV8-2, (B) B. pseudolongum DSMZ20099, (C) B. kashiwanohense PV20-2, and
(D) B. kashiwanohense DSMZ21854 to xylene (hydrophobicity) and chloroform (electron-donor properties). Bifidobacterial strains were grown in MRS-cys
and in CSDLIM without and with iron supplementation (mean ± SD, n = 3). [Fe-: without iron supplementation (1.5 µM), Fe2+: with iron supplementation (30 µM).]
S. Typhi N15 and E. coli O157:H45 which are known to
efficiently bind iron, were tested in vitro. Bifidobacteria may
exert inhibitory activity against enteropathogens by production
of organic acids, competition for essential growth nutrients,
production of antibacterial peptides and co-aggregation with
pathogens (Turroni et al., 2009; Butel, 2014; Ventura et al., 2014).
Organic acids can prevent infections of pathogens by lowering
the intestinal pH and hence restricting colonization of pathogenic
bacteria that are sensitive to low pH (Bernet et al., 1993; Lievin
et al., 2000; Shu et al., 2000; Gopal et al., 2001; Shu and Gill, 2001;
Hammami et al., 2013).
Co-cultivation experiments revealed the inhibitory effects
of Bp PV8-2 and Bk PV20-2 against S. Typhi N15 and
EHEC. Both enteropathogens were not affected by incubation
at low pH and organic acid concentrations produced by the
bifidobacteria strains during co-cultures. While growth of EHEC
was inhibited by Bp PV8-2 and slightly reduced by Bk PV 20-2
(not significantly), S. Typhi N15 was significantly reduced by
both bifidobacterial strains during co-cultures compared with
single cultures. The reduction of viability of enteropathogens in
co-cultures could be the result of different factors combined,
such as the fitness of the strain under test conditions, and high
iron sequestration mechanisms and the production of inhibitory
substances by bifidobacteria (Bailey et al., 2011). Additionally,
lactate and acetate, may also function as a permeabilizer of
the outer membrane of Gram-negative bacteria and may thus
accentuate the effects of other inhibitory substances, such as
bacteriocins (Oh et al., 2009).
For example, the extracellular proteome of Bp PV8-2 showed
the expression of a lysozyme that might contribute to the
inhibitory activity of the strain (Vazquez-Gutierrez, 2014), and
the effect might be increased by the production of organic acids
(Tejero-Sarinena et al., 2012). Both Bifidobacterium strains tested
were less efficient against EHEC, possibly because EHEC has
the ability to survive in many adverse conditions when it enters
starvation, allowing EHEC to adapt to very harsh conditions with
almost no available nutrients, including iron (Chekabab et al.,
2013).
Adhesion and Competition at the
Intestinal Epithelium
The potential of Bp PV8-2 and Bk PV 20-2 to compete for
adhesion sites was tested. Occupation of adhesion sites can reduce
pathogen adhesion to intestinal epithelium and is mediated by
bacterial surface properties like hydrophobicity and cell surface
proteins (Botes et al., 2008; Xu et al., 2009). Bp PV8-2 had high
affinity for the non-polar solvent xylene, indicating that this strain
has hydrophobic cell surface properties. In contrast Bk PV20-2
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FIGURE 4 | Adhesion of bifidobacteria and enteropathogens strains:
(A) to intestinal epithelial surface molecules (EMC) at pH 5.5
(mean ± SD, n = 3). (B) To intestinal EMC at pH 7.5 (mean ± SD, n = 3).
Stars denote significant (P < 0.05) adhesion to EMC compared with PBS.
was hydrophilic and showed no acid-base properties. The growth
medium of bifidobacteria had a strong effect on strain surface
property, in contrast with iron availability which did not affect
the surface characteristics. Affinity to solvents data indicated that
Bp PV8-2 has similar physico-chemical cell surface properties
to type strain Bp DSMZ20099. In contrast, affinities to solvents
of Bk PV20-2 and Bk DSMZ21854 were similar when both
strains were grown in MRS-cys but very different when grown
in CSDLIM, emphasizing the influence of growth conditions on
surface properties of bacterial strains (Xu et al., 2009). Canzi
et al. (2005) reported that even very close genetically related
bifidobacteria strains can exhibit significantly different adhesion
activities to hydrocarbons (xylene and hexadecane), supporting
high strain specificity (Del Re et al., 2000).
Adhesion affinity to different binding sites of the intestinal
epithelium was subsequently quantified by the adhesion affinity
to a representative set of surface glycoproteins. Specific binding
affinity to type II mucin was low for all strains, consistent with the
findings of Collado et al. (2005) who observed weak adherence
of bifidobacterial strains of human origin to human intestinal
mucus glycoproteins. Bk PV20-2 and Bk DSMZ21854 showed
affinity for fibronectin. Bk strains shared the binding affinity to
fibronectin with both enteropathogens (Fujiwara et al., 2001),
suggesting possible competition for intestinal binding sites by
Bk PV20-2 that could prevent infections (Collado et al., 2005;
Sperandio, 2012). Adhesion to extracellular glycoproteins of all
strains was increased at pH 5.5 compared with pH 7.5. The acid
environment resulting from the colonization of bifidobacteria
could further support the competition for the epithelial binding
sites, emphasizing the importance of the combined effect of
physico-chemical affinity and surface properties (de Wouters
et al., 2015; Jans et al., 2016).
Competition between bifidobacteria strains and entero
pathogens by competition, displacement and inhibition was
FIGURE 5 | Adhesion ratios of bifidobacteria and enteropathogens measured during competition, displacement and inhibition tests performed with
mucus-producing HT29-MTX cell line: (A) B. pseudolongum PV8-2 (Bp PV8-2) and S. Typhimurium N15 (S. Typhi N15); (B) B. kashiwanohense PV20-2
(Bk PV20-2) and E. coli O157:H45 (EHEC); (C) Bk PV20-2 and S. Typhi N15; (D) Bk PV20-2 and EHEC. The adhesion ratio corresponded to the ratio of the
percentage of adhered bifidobacteria or pathogenic bacteria following simultaneous addition divided by the percentage of adhesion of the Bifidobacterium strain or
pathogenic bacteria added alone to the cell culture. Dotted line (adhesion ratio = 1) indicates no effect of interactions of tested cultures. Columns with a star (*)
indicate significantly different (P < 0.05) values when compared to 1 (mean ± SD, n = 3).
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then studied on a differentiated, mucus-secreting HT29-MTX
cells monolayer. In agreement with adhesion tests with single
surface molecules, Bp strains showed only modest adhesion
abilities to mucus-secreting HT29-MTX cells compared with
Bk strains, S. Typhi N15 and EHEC. The high adhesion
properties of both enteropathogens may reflect growth of the
strain during the incubation test with cell layers as previously
reported for Salmonella in a similar cell test (Dostal et al.,
2014). Several studies suggest correlation between adhesion
to intestinal cells and cell surface hydrophobicity measured
with the BATS assay (Marin et al., 1997; Del Re et al.,
2000), a result which was not confirmed in other studies
(Savage, 1992; Ouwehand et al., 1999; Canzi et al., 2005;
de Wouters et al., 2015). Even though hydrophobicity did
not correlate with adhesion properties, BATS assay showed
that cell surface properties of Bp PV8-2 and Bk PV20-2 are
different, indicating strain-specificity. Bk PV20-2 strain showed
no hydrophobic affinity suggesting that adhesion might be
mediated by adhesion-like factors (Turroni et al., 2009; Ventura
et al., 2014).
Adhesion properties of beneficial bifidobacteria to the mucosa
have been shown to promote gut residence time, pathogen
exclusion, protection of epithelial cells and immune modulation.
Our data indicated that the degree of competition was dependent
on bifidobacteria and enteropathogen strain. While both
bifidobacteria strains were able to competitively exclude S. Typhi
N15, only Bp PV8-2 was able to decrease the adhesion capacity
of EHEC. In the presence of Bk PV20-2 adhesion of EHEC was
increased, suggesting a sharing of metabolic activities leading
to enhanced adhesion (Collado et al., 2005). Previous studies
reported increased enteropathogen adhesion by bifidobacteria.
For example under similar experimental conditions, Serafini
et al. (2013) investigated antagonistic effects of Bifidobacterium
bifidum PRL2010 against various enteropathogens, including
S. Typhi and EHEC on HT-29 cells not secreting mucus
(Gueimonde et al., 2006; Serafini et al., 2013). Our data suggests a
direct competition for binding sites that protect the host against
invasion of enteropathogens which might also be influenced
by strain fitness related to iron sequestration mechanisms
(Chauviere et al., 1992; Lee and Puong, 2002). Both Bp PV8-2
and Bk PV20-2 resulted in marked reductions in adhesion of S.
Typhi N15 and EHEC, indicating that colonization with these
potential probiotic candidates selected for high iron sequestration
mechanisms might offer at least partial protection from infection
with enteropathogenic bacteria (Collado et al., 2007). Further
experiments have to be performed in vivo to support these
effects.
CONCLUSION
Ability of commensals such as bifidobacteria to restrain pathogen
growth in the intestine is strongly affected by niche and nutrient
competition. Our study showed that B. pseudolongum PV8-2
and B. kashiwanohense PV20-2, selected for their high iron
sequestration mechanisms, exhibited strain-dependent inhibitory
activity against S. Typhi N15 and EHEC. These strains may
be potential probiotic candidates especially for inhibiting iron-
dependent enteric pathogens such as enterobacteriaceae in the
gut. The biological significance of such competitive probiotics
and their potential as preventive or curative probiotics should
be further investigated in vitro in presence of complex gut
microbiota and in vivo with animal models.
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